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SUMMARY

Early events in atherosclerosis occur in the aortic
intima and involve monocytes that become macrophages. We looked for these cells in the steady state
adult mouse aorta, and surprisingly, we found a
dominance of dendritic cells (DCs) in the intima.
In contrast to aortic adventitial macrophages,
CD11c+MHC IIhi DCs were poorly phagocytic but
were immune stimulatory. DCs were of two types
primarily: classical Flt3-Flt3L signaling-dependent,
CD103+CD11b DCs and macrophage-colony stimulating factor (M-CSF)-dependent, CD14+CD11b+DCSIGN+ monocyte-derived DCs. Both types expanded
during atherosclerosis. By crossing Flt3 / to Ldlr /
atherosclerosis-prone mice, we developed a selective and marked deficiency of classical CD103+ aortic
DCs, and they were associated with exacerbated
atherosclerosis without alterations in blood lipids.
Concomitantly, the Flt3 / Ldlr / mice had fewer
Foxp3+ Treg cells and increased inflammatory cytokine mRNAs in the aorta. Therefore, functional DCs
are dominant in normal aortic intima and, in contrast
to macrophages, CD103+ classical DCs are associated with atherosclerosis protection.

INTRODUCTION
Large numbers of inflammatory and immune cells are found
in the aorta during several vascular diseases including atherosclerosis, giant cell arteritis, and aortic aneurysm (Hansson and
Libby, 2006; Kuivaniemi et al., 2008; Weber et al., 2008; Weyand
et al., 2004). In addition to atherosclerosis being a chronic inflammatory disease of the aorta and large blood vessels (Ross, 1999),
it is also at least in part an immune disease (Hansson and Jonasson, 2009; Ross, 1999). The precise definition of the development and function of immune cells in normal and diseased
vessels is therefore increasingly important.

In the initial stages of atherosclerosis, blood monocytes enter
the subintimal space and take up lipids to become foam cells
(Lessner et al., 2002). T cells also accumulate in the atherosclerotic
plaque (Gown et al., 1986; Hansson et al., 1989; Jeon et al., 2010;
Jonasson et al., 1986). Previous studies indicate that a major autoantigen for human T cells from fresh intimal plaques is oxidized
LDL (oxLDL), which upon activation release atherogenic chemokines, like monocyte chemoattractant protein-1 (MCP-1) (Hansson et al., 2002; Stemme et al., 1995). Alternatively regulatory T
(Treg) cells are present and are reported to attenuate atherosclerosis (Ait-Oufella et al., 2006; Mallat et al., 2003; Mor et al., 2007;
Sasaki et al., 2009; Takeda et al., 2010). However, a bidirectional
link between monocytes and T cells is perplexing because monocytes are poor immune-stimulating cells (Van Voorhis et al., 1983)
until they differentiate into dendritic cells (DCs) (Romani et al.,
1994; Sallusto and Lanzavecchia, 1994). Interestingly, transfer of
DCs loaded with oxidized LDL can protect rather than enhance
atherosclerosis (Habets et al., 2010). Therefore, if lipoproteins
mediate an interaction between antigen-presenting cells and
T cells in the atherosclerotic intima (Sun et al., 2010) (Benagiano
et al., 2005), it becomes important to know the extent and type
of antigen-presenting cells in this site in vivo and to find out
whether some have the capacity to protect against disease.
The expression of surface molecules MHC class II (MHC II),
CD11b, CD11c, and CD68 has been used for identifying presumptive macrophages and DCs in mouse aorta (Galkina
et al., 2006), whereas staining for CD68 and CD11c has localized
these cells to the intima of the lesser curvature of the aortic arch
and openings of arterial branches, which are atherosclerosisprone areas (Jongstra-Bilen et al., 2006). Expression of CD11c
also has been used to mark presumptive DCs that accumulate
lipid during atherosclerosis (Cybulsky and Jongstra-Bilen,
2010; Paulson et al., 2010). It is proposed that aortic DCs are
inflammatory, derived from monocytes, and increased during
atherosclerosis (Liu et al., 2008).
However, the early research discriminating DCs from monocytes did not employ the functional and developmental criteria
that are valuable for identifying and understanding cell function
(Cheong et al., 2010a; Liu et al., 2009), and these criteria might
likewise be critical to understand atherosclerosis and develop
new approaches and tools for the field.
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Figure 1. Presence of Flt3L-Dependent DCs in Aortic Intima
(A) FACS procedures for analysis of aortic leukocytes in enzyme digested aorta. The liberated cells were stained for CD45, CD11c, CD11b, F4/80, MHC II, CD3,
and CD19 and analyzed with a LSRII instrument (BD).
(B) Ten micrograms of Flt3L was injected i.p. for nine consecutive days, and then aortic leukocytes were analyzed by FACS to show selective increase in
CD11c+MHC IIhi cells (arrow, top right).
(C) As in (B), showing marked increase in intimal CD11c+ cells (red) by en face immunostaining of aorta from Flt3L treated mouse. The figures in each section are
representative of at least three experiments.

Here, we localize and characterize aortic mononuclear cells,
emphasizing newly appreciated evidence for two major pathways of DC development, one driven by the cytokine fms-like
thyrosine kinase 3 ligand (Flt3L) and its receptor (Flt3) acting
on monocyte-independent precursors (Liu et al., 2009; Naik
et al., 2006; Onai et al., 2006) and another from monocytes independently of Flt3L-Flt3 (Cheong et al., 2010a). Surprisingly we
find that the nonlymphocytes of the subintima in the steady state
are mainly comprised of poorly phagocytic, immune stimulatory
DCs, not monocytes, and that these are derived from both major
developmental pathways: Flt3-Flt3L dependent classical DCs,
and M-CSF dependent monocyte-derived DCs. Both cell types
are found in diseased mouse aorta as well. Whereas most types
of immune cells are thought to exacerbate atherosclerosis
(Stoneman et al., 2007; Sun et al., 2007b; Whitman et al., 2004;
Zhou et al., 2000), we find that Flt3-deficient low-density lipoprotein receptor knockout (Ldlr / ) mice have lower numbers of
820 Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc.

classical DCs and develop more severe atherosclerosis relative
to control Ldlr / mice. Flt3 deficient Ldlr / mice have less
Tregs and more inflammatory cytokines in the aorta. Our findings
indicate that classical DCs, in contrast to monocytes and macrophages, have an atheroprotective function.
RESULTS
Flt3L treatment Selectively Increases CD11c+MHC IIhi
Cells in the Aorta
To better identify different cell types in the normal mouse aorta,
we developed a multicolor flow cytometry procedure for cell
suspensions from the aortic root (valves and aortic sinus) and
both ascending and descending aorta. The aorta was dissociated with an enzyme mixture and then stained with monoclonal
antibodies for dissecting the subset of leukocytes. CD45+ leukocytes (Figure 1A, top left) were further defined with CD11c and
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MHC II in looking for CD11c and MHC II-high, presumptive DCs
(Figure 1A, second from left). Among the CD45+ leukocytes
(average yield about 10,000/aorta; 1%–2% of the aortic cell
suspension), we observed a minor fraction of CD11c+MHC IIhi
cells (Figure 1A and Figure S1A available online), which we
showed previously had immune stimulating and cross-presenting capacities similar to DCs from lymphoid tissues (Choi et al.,
2009). The CD11c cells were comprised of a major population
that double labeled for F4/80 and CD11b (Figure S1A). Many of
the latter cells expressed lower surface MHC II molecules
compared with CD11c+MHC IIhi cells (MFI: 1.3 3 104 versus
5.2 3 104, Figure S1B). MHC II expression on these F4/80+
CD11b+CD11c cells was comparable to B cells (Figure 1A
and Figure S1A). After immunolabeling, in contrast to the
CD11c+ cells in the intima of normal aorta (Choi et al., 2009),
but F4/80+ cells were abundant in adventitia
CD11c
(Figure S1C).
To gain developmental evidence that the CD11c+MHC IIhi cells
were DCs, we treated mice with 10 mg of Flt3L for nine consecutive days as described in previous studies showing the expansion of DCs but not macrophages in response to Flt3L in
lymphoid and nonlymphoid tissues (Ginhoux et al., 2009; Waskow et al., 2008). Aortic CD11c+MHC IIhi cells were increased
2.5- to 3-fold in Flt3L-treated mice (Figure 1B, arrow), whereas
other populations were slightly increased or not changed (Figure 1B). When we checked for the distribution of the Flt3L-mobilized DCs by en face immunostaining, the CD11c+ cells were
markedly increased in both the intima and adventitia of Flt3Ltreated mice (Figure 1C). This approach provides developmental
evidence that CD11c and MHC II-high cells in the aorta include
DCs whereas the CD11c cells are primarily macrophages expressing higher amounts of F4/80 and CD11b and lower expression of MHC II than the DCs (Figures S1A and S1B).
Aortic Dendritic Cell and Macrophage Populations Can
Be Distinguished by Functional Criteria
To test whether F4/80+CD11b+ cells had the phagocytic activity
of macrophages, we bathed aortic cell suspensions in serumcontaining RPMI medium with 0.5 mm fluorescent YG microspheres, and 70 min later, we analyzed the phagocytic activity
with ImageStream analysis and flow cytometry; the former
allows one to visualize single cells for uptake and other cell
surface markers simultaneously. CD11c+MHC IIhi DCs took up
0–1 bead (Figure 2A, top three rows), whereas phagocytic
activity was clearly evident in the CD11c CD11b+MHC II
macrophages (Figure 2A, middle three rows). The CD45+
CD11c CD11b fraction was also nonphagocytic (Figure 2A,
lower three rows). These findings were confirmed by FACS analysis (Figure 2B).
To identify cell populations with the immune-stimulatory
capacity of DCs, we sorted cell fractions and tested them for
stimulation of T cells in the primary mixed leukocyte reaction
(MLR) (Figure 2C). Only the CD11c+MHC IIhi aortic cells were
strong stimulators of proliferation in both CD4+ and CD8+
T cells (Figure S2) and similar to that observed with splenic
DCs (Figure 2C). In contrast the macrophage and lymphocyte
fractions, which included MHC II+ macrophages and B cells,
were nonstimulatory (Figures 2C and S2). Therefore, by functional criteria, aortic cell suspensions have a major population

of phagocytic, nonimmune stimulatory macrophages and
a minor population of poorly phagocytic, immune stimulatory
DCs (Steinman and Cohn, 1974; Steinman and Witmer, 1978).
CD11c–F4/80+CD11b+ Aortic Cells Are Selectively
Ablated by Two Monocyte Depletion Methods
To evaluate the effects of monocyte depletion, we first injected
diphtheria toxin (DT) into CD11b-DTR mice, which specifically
depletes monocytes (Duffield et al., 2005; Stoneman et al.,
2007). When we checked aortic CD45+ leukocytes, the
CD11c phagocytes with high expressions of F4/80 and
CD11b were markedly decreased, whereas CD11c+MHC IIhi
DCs were still intact (Figure 3A, arrows). The resistance of the
DCs to DT was to some extent surprising because, as will be
shown below, some aortic DCs do express intermediate levels
of CD11b, as is also the case with CD8 CD11b+ spleen DCs.
However, we also observed that splenic DCs but not splenic
monocytes and macrophages were resistant to DT treatment
(Figure S3A). Therefore, this depletion method depletes monocytes and macrophages, but does not deplete the DC subset
in spleen or aorta that expresses CD11b. This surprising resistance of DCs in spleen and aorta of CD11b-DTR mice to DT
treatment may reflect lower and/or less stable DTR expression,
and interestingly CD11b+ neutrophils also have been reported
to be resistant to DT depletion in these transgenic mice (Duffield
et al., 2005).
To analyze development at the level of hematopoietins, we
also investigated op/op mice that lack the M-CSF hematopoietin
for monocytes and macrophages but not most DCs in lymphoid
tissues in steady state (Witmer-Pack et al., 1993). CD11c F4/
80+CD11b+ macrophages in the aorta of op/op mice were
decreased by 90% compared with WT control mice (Figure 3B,
arrow). However, the other populations remained intact (Figure 3B and Figure S3B). Thus, the results from CD11b-DTR
and op/op mice suggest a monocyte origin of CD11c F4/
80+CD11b+ cells.
Two Major Subsets of Dendritic Cells in Normal
Mouse Aorta
To extend the above genetic approaches to DCs, we first determined whether aortic DCs were comprised of subsets, as is the
case in many lymphoid and nonlymphoid tissues (reviewed in
Merad and Manz, 2009). When we stained the intimal CD11c+
cells in intact aortic tissue for CD11b, there appeared to be
two subsets, i.e., CD11b-negative and -positive, CD11c+ cells
(Figure 4A). By FACS analysis, we could also see CD11b+F4/
80+ and CD11b F4/80 DC subsets, as well as a small
CD11b+F4/80 population. The low frequency of the latter cells
prevented further study at this time (Figure 4B). B220+CD19
plasmacytoid DCs also were scarce (data not shown).
To verify that the CD11b F4/80 aortic DCs were comparable
to what are termed CD8a+ DCs in lymphoid organs, we examined
these DCs for their marker expression. We found that aortic DCs
did not express CD8, CD205, and 33D1 (data not shown).
However, when we tested for expression of CD103, a ligand for
E-cadherin expressed by most epithelial cells and also a marker
for CD11b DCs in many tissues (Annacker et al., 2005; Edelson
et al., 2010; Johansson-Lindbom et al., 2005; Merad and Manz,
2009; Sung et al., 2006), most CD11b F4/80 DCs expressed
Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc. 821
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Figure 2. Distinguishing Aortic Dendritic Cell and Macrophage Populations by Functional Criteria
(A and B) Uptake of 0.5 mm microspheres (YG, Molecular Probes) after 70 min exposure of aortic segments that had been digested with the enzyme mixture by (A)
ImageStream and (B) FACS.
(C) Stimulation of CD3+ CFSE-labeled T cells in the mixed leukocyte reaction (methods) by different populations of aortic cells DCs, e.g., CD45+CD11c+MHC IIhi
DCs (lower right) and macrophages, (CD45+CD11c MHC II+, CD45+CD11c MHC II ) upper row. Splenic (Sp) CD11c+MHC IIhi DCs were isolated from C57BL/6
and BALB/C (syngeneic) mice for positive and negative controls of the MLR, respectively. CFSE dilution was analyzed 5 days later. Each figure is representative of
three experiments.

CD103 in normal aorta (Figure 4C, blue), and this molecule was
not found on any other population of aortic leukocyte (data not
shown). Furthermore, these CD103+ DCs selectively expressed
Langerin (CD207) (Kissenpfennig et al., 2005; Cheong et al.,
2007) (Figure S4).
When we separately examined aortic cells from the aortic
sinus and the rest of the aorta (aortic arch and thoracic aorta),
most CD103+CD11b F4/80 DCs were from the aortic sinus,
but these cells were also present in other regions of the aorta
in smaller amounts (Figure 4D, blue population). To further define
the exact location of these cells in the aortic wall, we analyzed
the aortic DC populations after removing the adventitial tissue.
Surgical removal of adventitial tissues increased the frequency
of CD11c+ DCs in the recovered CD45+ leukocytes, but
decreased the frequency of macrophages. These results indi822 Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc.

cate that DCs are more localized to the intima than adventitia
whereas macrophages are mainly localized in the adventitia
(Figure 4E). We tentatively concluded that the aortic intima had
two major subsets of DCs (Figure S4B): CD103+CD11b F4/
80 and CD103 CD11b+F4/80+ populations.
CD11b– F4/80– Aortic DCs Selectively Express Flt3
and Respond to Flt3 Ligand
To extend prior work showing expression of Flt3/CD135, the
receptor for Flt3L on classical DCs, we found unexpectedly
that CD135 was detected primarily on CD11b aortic DCs by
FACS, and not all DCs (Figure S5A, population I), as anticipated
from prior work (Liu et al., 2009; Naik et al., 2006; Onai et al.,
2006). To pursue this finding, we investigated Flt3-deficient
(Flt3 / ) mice and found that the total CD11c+MHC IIhi DCs
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Figure 3. Ablation of CD11c– F4/80+ CD11b+ Aortic Cells by Two Monocyte Depletion Methods
(A) Selective depletion of aortic CD11c CD11b+F4/80+ cells by 0.5 mg DT i.v. (25 ng/g weight) after 24 hr in CD11b-DTR transgenic mice.
(B) Marked depletion of CD11c CD11b+F4/80+ cells (arrow) in M-CSF deleted op/op mice. Each figure is representative of at least three experiments.

were slightly decreased but the CD11b F4/80 population was
selectively and markedly decreased (Figure 5A, arrow, middle
row). Likewise, CD103+ DCs were also markedly reduced in
Flt3 / mice (Figure 5A, arrow, lower row). When we tested
responses to Flt3L treatment, F4/80 DCs, both CD11b and
CD11b+ DC subsets, were markedly increased (Figure 5B, upper
panels), whereas CD11c F4/80+CD11b+ macrophages were not
(Figure 5B, lower panels). The Flt3 requirement was cell intrinsic
because when we injected 1:1 mixtures of C57BL/6 (B6) WT
(CD45.2) and Flt3 / (CD45.1) marrow into lethally irradiated
CD45.2 B6 (5.5 Gy 3 2, 3 hr apart) mice, 25% of blood leukocytes were from the Flt3 / donor at 6 weeks. When we checked
the aortic CD11c+MHC IIhi populations, we found that marrow
cells from Flt3 / mice failed to make a CD11b F4/80 population, indicating that the generation of CD11b F4/80 cells is
highly dependent on Flt3 signaling (Figure S5B). Corroborating
our findings is the fact that Flt3L-deficient mice also selectively
lack CD103+DCs (Figure S5C). These data indicate that
CD11b F4/80 CD103+ cells in the aorta are typical Flt3-dependent DCs, but the CD11b+F4/80+ DCs are not.
CD11b+ F4/80+ CD103– DCs Express CD14 and DC-SIGN
and Are M-CSF Dependent
To determine whether CD11b+F4/80+CD103 DCs were related
to monocyte-derived DCs, as described in a recent paper
(Cheong et al., 2010a), we added CD14 as a marker. We found
the CD11b+CD103 cells expressed the CD14 coreceptor for
TLR4 and also that injected DC-SIGN antibody (BMD30)
(Cheong et al., 2010b) could label these cells (Figures 6A and
6B). Furthermore, in op/op mice, this population was dramatically decreased, indicating that these cells also require M-CSF
(Figures 6C and S6A). These results indicate that the CD11b+
CD103 population are not the equivalent of CD8a DCs, which
are monocyte independent, but are consistent with an origin
from monocytes.
Previous studies (Liu et al., 2009; Naik et al., 2006; Onai et al.,
2006) showed that classical DCs originate from DC precursors
with low expression of CX3CR1, whereas monocytes and monocyte-derived cells have higher CX3CR1 expression. We next
checked for CX3CR1 expression of each aortic DC population.
CX3CR1 was expressed only by CD11b+F4/80+ DCs and
CD11b+F4/80 DCs and absent from CD11b F4/80 population
(Figures S6B and S4B).

To confirm that these CD14+CD11b+ cells were monocytederived DCs, functional tests were done. Both CD14+ CD103
and CD14 CD103+ DCs were poorly phagocytic (Figure S6C,
also see Figure 2A for morphology). When we tested their
capacity to stimulate T cells in the MLR, the CD14+ and CD14
cells were as immune stimulatory as splenic DCs (Figure 6D).
Thus, CD11c+MHC IIhi DCs of the aorta are of two types, Flt3
and M-CSF dependent, and both are poorly phagocytic and
strongly stimulatory for T cell responses.
Both DC Subsets Are Increased in Atherosclerotic Aorta
and Flt3-Dependent DCs Are Atheroprotective
To examine aortic DC subsets in the atherosclerotic aorta, we
used Ldlr / mice that were fed a high cholesterol diet for
16 weeks. Initially, we double-stained whole mount of the atherosclerotic aorta with antibodies to CD11c and F4/80 and could
find both DCs (CD11c+F4/80 , CD11c+F4/80+) and macrophages (CD11c F4/80+) in the atherosclerotic intima (Figure S7A). Shown by FACS, atherosclerotic aorta had more
CD45+ leukocytes and CD11c+MHC IIhi DCs than normal aorta,
approximately 34 fold and 810 fold respectively (Figure S7B).
When we analyzed the CD11c+MHC IIhi DCs, the CD11b+F4/80+
population was more dramatically increased throughout the
aorta including the aortic sinus, aortic arch, and thoracic aorta
(Figure S7B), but CD103+ DCs were also increased in atherosclerotic relative to normal aorta (Figure S7C).
To pursue the Flt3 dependence of the aortic cell subsets in
disease, we generated atherosclerotic mice lacking Flt3 by
crossbreeding Ldlr / to Flt3 / mice. We confirmed that more
than 99% of makers between Flt3+/+Ldlr / and Flt3 / Ldlr /
mice were identical in microsatellite genotyping for C57BL/6
genetic background (data not shown). Flt3+/+Ldlr / and
Flt3 / Ldlr / mice were fed a high-fat diet for 12 weeks, and
we checked the aortic DC populations. The CD11b CD103+
DCs were again highly dependent on Flt3 in atherosclerotic
mice (Figure 7A, arrow), whereas CD11b+CD103 DCs were
able to expand in the Flt3 / Ldlr / mice (Figure 7A). This result
shows that DCs in atherosclerotic aorta can be generated from
a classical Flt3-dependent DC precursor.
To understand the role of classical DCs in the development of
atherosclerosis, we measured the lesion size in the aortic sinus
of Flt3 / Ldlr / mice compared with Flt3+/+Ldlr / mice. The
average lesion size of Flt3 / Ldlr / mice was increased by
Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc. 823
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(A) Double en face immunostaining for CD11c and CD11b in aortic intima to show that intimal CD11c+ cells are either CD11b positive or negative.
(B) FACS analysis of CD11c+MHC IIhi CD45+ aortic cells (red box) showing two major populations including CD11b+F4/80+ and CD11b F4/80 DCs.
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(E) Enrichment of the frequency of DCs by removal of adventitia (Adv) without altering the numbers of the DC subsets. Error bars refer to standard deviation.
Each figure is representative of at least three experiments.

69% compared with Flt3+/+Ldlr / mice (Figure 7B). In the aortic
arch, the average lesion size of Flt3 / Ldlr / mice was also
increased compared with Flt3+/+Ldlr / mice (Figure 7C); the
increase was smaller than in the aortic sinus, presumably
because the aorta naturally has a smaller representation of
Flt3-dependent DCs than the aortic sinus as shown above. The
plasma lipid profiles were not different between Flt3 / Ldlr /
and Flt3+/+Ldlr / mice (Figure S7D), suggesting that the Flt3dependent DCs were operating to reduce inflammation and
immunity, not lipid metabolism. To understand the proatherogenic events in Flt3 / Ldlr / mice, we analyzed T cells in the
atherosclerotic mice. Although total T cell numbers were not
altered, the percentages of Treg cells in the aorta were markedly
reduced in Flt3 / Ldlr / mice compared with Flt3+/+Ldlr /
mice (Figure 7D). To determine whether the lack of Treg cells
was associated with more inflammation, we measured the
expression of mRNA for the inflammatory cytokines IFN-g and
824 Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc.

TNF-a in the aorta itself, and both were markedly increased in
Flt3 / Ldlr / mice than controls (Figure 7E). These results
indicate that Flt3-dependent classical DCs have an atheroprotective effect, possibly through increasing the regulatory T cell
population.
DISCUSSION
Although macrophages in the aorta and large vessels have been
the object of longstanding and considerable research (Woollard
and Geissmann, 2010), studies on aortic DCs are more recent
and less numerous (reviewed in Cybulsky and Jongstra-Bilen,
2010). Here, we compared DCs and macrophages side by side
in the mouse aorta, whereas prior work has focused on one
cell type or the other. Our first emphasis was to determine
whether basic functional distinctions that have been evident in
lymphoid and other nonlymphoid tissues were also evident in
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Figure 5. Dependence of CD11b–F4/80–CD103+ DCs on the Flt3-Flt3L Pathway
(A) Selective decrease of CD11b F4/80 CD103+ DCs in Flt3-deficient mice (arrows).
(B) Expansion of F4/80 DCs by Flt3L treatment for 9 consecutive days, including a CD11b+F4/80 population that was a scant population in steady state aorta.
The expansions of these cells by Flt3L treatment were occurred in overall aorta including aortic sinus, aortic arch and descending aorta. Each figure is representative of at least three experiments.

the aorta. In fact, macrophages from the aorta were actively
phagocytic but poorly immune stimulatory, whereas DCs were
poorly phagocytic but strongly immunostimulatory. DCs were
MHC IIhi and most macrophages MHC IIlo, but a subset of
macrophages did express MHC II. The latter population was
also inactive in stimulating the MLR, which is a test for the
capacity of antigen-presenting cells to initiate immunity from
many T cell clones in the polyclonal repertoire. It is possible
that the aortic macrophages, many of which are in the adventitia,
include monocytes capable of giving rise to either macrophages
or monocyte-derived DCs. Nonetheless functionally distinct
macrophages and DCs are found in the aorta as is the case
with most tissues.
Aortic macrophages, which had low CD11c expression but
high F4/80 and CD11b, were surprisingly localized to the adventitia of the aorta in steady state, except in the case of the aortic
valve and sinus where macrophages were also noted in the
intima. In contrast, DCs were CD11c+MHC IIhi and were the
dominant cell in the intima. As summarized in the introduction,

prior emphasis has been on the monocyte as the principal cell
in the aortic intima, but in the steady state, we found that
CD11c+MHC IIhi DCs dominated.
To further characterize the intimal cells as DCs, we examined
their developmental origin. Surprisingly, both major pathways of
DC development, termed classical and monocyte-derived DCs
(Mo-DCs), were juxtaposed in the intima. The classical pathway
is marked by CD103 and CD135 but lacks CX3CR1, CD11b,
and F4/80. It is dependent on Flt3-Flt3L for its development.
The Mo-DC pathway lacks CD103 but expresses CX3CR1,
CD11b, F4/80, CD14, and DC-SIGN. It is dependent upon
M-CSF for its development. Both types of DCs, after isolation
from mice, function as classical mature DCs, lacking phagocytic
activity but exerting strong stimulation of T cells (Steinman and
Cohn, 1974; Steinman and Witmer, 1978).
Both types of DCs also were increased in experimental atherosclerosis, although the Mo-DCs increased to a greater extent.
Recently, we and others found that Mo-DCs do exist in lymph
nodes in the steady state but increase markedly upon microbial
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(A) The expression of CD14 on the CD11b+CD103 subset of CD11c+MHC IIhi DCs. As positive control (lower row), the aortic macrophages (CD11c CD11b+F4/
80+) were stained for CD14.
(B) Labeling of the CD11b+CD14+ subset of DCs by DC-SIGN (blue dots). DC-SIGN antibody was injected i.v. for 12 hr (10 mg of Alexa647 labeled BMD30 clone).
(C) Depletion of CD11b+F4/80+ population in CD11c+MHC IIhi DCs from the aorta of op/op mouse. Each figure is representative of at least three experiments.
(D) Stimulation of MLR by CD14+ DCs (C57BL/6) mixed with CFSE-labeled T cells. The arrow indicates CFSE-dilution of CD3+ T cells (BALB/c). Syngeneic DCs
were from the spleen of BALB/C mouse. Each figure is representative of two or three experiments.

infection (Cheong et al., 2010a) or some conditions of chronic
inflammation such as colitis (Siddiqui et al., 2010). However,
there are no decisive genetic tools yet to selectively ablate
Mo-DCs transiently or constitutively. Genetic models currently
available such as CD11c-DTR, CD11b-DTR, and LysM-Cre 3
iDTR also affect monocyte and macrophage populations.
With these developmental criteria, we could perform experiments that provided unexpected results on the role of classical
DCs in atherosclerosis. When Flt3 was genetically deleted
from Ldlr / atherosclerosis-prone mice, the corresponding
826 Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc.

DC subset was selectively lost from the aorta, and atherosclerosis was aggravated. This indicates that Flt3+ DCs protect
against this inflammatory disease. In contrast M-CSF is known
to be a proatherogenic molecule (Chitu and Stanley, 2006;
Rajavashisth et al., 1998), although it is not yet clear whether
this effect is entirely from monocytes and macrophages or also
includes Mo-DCs.
A prior study immunized Ldlr / mice with bone marrowderived DCs that had taken up oxidized low-density lipoproteins and observed a protective effect of such ‘‘DC vaccines’’
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(Habets et al., 2010). However, research on the effect of DC
alterations in situ in atherosclerosis has not provided a clear
picture. When the life span of DCs was prolonged with
CD11c-hBcl2 transgenic mice, plasma lipids were decreased,
whereas DC ablation with CD11c-DTR transgenic mice
increased blood lipids (Gautier et al., 2009). Cybulsky and his
colleagues recently demonstrated that DC ablation in CD11cDTR transgenic mice reduced intimal lipid accumulation, suggesting a proatherogenic role in early disease (Cybulsky and
Jongstra-Bilen, 2010; Paulson et al., 2010). A difficulty with
prior work is that CD11c expression in atherosclerotic aorta is
not restricted to DCs but expressed by macrophage foam cells
(Cho et al., 2007), which we confirmed by noting CD11c+ but
MHC II foam cells in atherosclerotic mouse aorta (data not
shown). Moreover, it is not possible to dissect the function of
DC subtypes with CD11c-DTR mice given that CD11c is expressed on both major DC types in the aorta. Currently, the
developmental approaches used here seem to be more
discriminating for identifying the functions of DCs in situ, as
illustrated by the atheroprotective effects we found in mice
deficient for Flt3.
In addition to monocyte-derived DCs, the aorta has Flt3Flt3L-dependent classical DCs, from the CD103+CD11b F4/
80 population. In steady state, these DCs are mainly localized
in the aortic sinus. But, in atherosclerosis, we could see the
increase of these DCs in the overall aorta. It has been known
that classical DCs can induce a tolerance in steady state,
and constitutive DC ablation can develop autoimmune disease
(Ohnmacht et al., 2009). For example, the CD103+ CD11b
subset of DCs in the intestinal mucosa is able to induce
Foxp3+ regulatory or immune-suppressive CD4+ T cells
(Coombes et al., 2007; Sun et al., 2007a), and these T cells
have been implicated in the reduction of atherosclerosis (AitOufella et al., 2006). When Flt3 was genetically deleted from
Ldlr / atherosclerosis-prone mice, the corresponding DC
subset was selectively lost from the aorta, and atherosclerosis
was aggravated considerably. Foxp3+ T cells were decreased
in Flt3-deficient atherosclerotic mice, and others have reported
that increased Treg cells in lymphoid tissues are associated
with reduced atherosclerosis (Ait-Oufella et al., 2006; Mor
et al., 2007; Hermansson et al., 2011). It is known that the
numbers of Flt3+ DCs and Treg cells are reciprocally related
(Darrasse-Jèze et al., 2009). While revising our manuscript,
a subset of CD11b+DCs expressing CCL17-EGFP was reported to restrain the homeostasis of Treg cells, thereby
promoting atherosclerosis (Weber et al., 2011) in contrast to
the expansion of Treg cells by cDCs reported here. The developmental origin and function of CCL17-EGFP+ CD11b+DCs
also remains to be explored. Here, we extended prior work
by showing that the decrease in Treg cells in Flt3 / Ldlr /
mice is also associated with higher expressions of mRNA for
two inflammatory cytokines tested, IFN-g and TNF-a, in the
aorta itself. These findings provide a more precise developmental and functional picture of the cell types in the aorta
that is very different from prior analyses that were based on
cell surface markers primarily and support the view that ‘‘the
immune response in atherosclerosis is a double edged sword,’’
with one subset of DCs providing a protective edge (Hansson
and Libby, 2006).
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EXPERIMENTAL PROCEDURES
Mice
Ldlr / , CD11b-DTR, op/op, and Cx3cr1gfp/+ mice were obtained from
Jackson laboratory. Flt3 / mice (Matthews et al., 1991) (I. Lemischka, Mount
Sinai School of Medicine) were a generous gift of M. Nussenzweig. LangerinEGFP mice were a generous gift of B. Malissen. DC-SIGN/Cd209a / mice
were from the Consortium for Functional Glycomics (Scripps Res. Inst., La
Jolla, CA, USA). We used C57BL/6 (CD45.1 or CD45.2) mice and BALB/C
mice from Taconic. Mice were maintained under specific pathogen-free
conditions and fed ad libitum a normal mouse diet unless indicated. All mice
were used in accordance with guidelines of the Institutional Animal Care and
Use Committee, the Rockefeller University.
Antibodies and Reagents
mAb to cell surface markers CD14 and CD103 were from eBioscience and all
others from BioLegend. Anti-Foxp3 antibody and Foxp3 staining buffer set
were from e-Bioscience. Dynalbeads and Tyramide signal amplification
(TSA) kit were from Invitrogen. Collagenase I, collagenase XI, hyaluronidase,
and DNaseI were from Sigma Aldrich. Mouse Flt3 ligand was produced in
house as described (Darrasse-Jèze et al., 2009).
Aortic Single-Cell Preparations and Flow Cytometric Analysis
Aortic single cells were prepared in accordance with a previous method (Choi
et al., 2009) with minor modification. In brief, after careful removal of the
perivascular fat and cardiac muscle tissues, with microscissors under a dissecting microscope, single-cell suspensions from aortic segments, including
aortic sinus, or aortic arch and thoracic aorta, were prepared by incubation
with an enzyme mixture containing 675 U/ml collagenase I, 187.5 U/ml collagenase XI, 90 U/ml hyaluronidase, and 90 U/ml DNase in Hank’s balanced
salt solution with calcium and magnesium for 75 min at 37 C with gentle
shaking. Splenic single-cell suspensions were prepared by incubation with
400 U/ml collagenase D at 37 C for 30 min. After blocking Fc receptors
with culture supernatant from the 2.4G2 hybridoma, the cells were stained
with the indicated fluorochrome-conjugated antibodies. We used LSRII instrument (BD) and analyzed flow cytometric data with FlowJo (Tree Star Inc).
Analysis of Phagocytosis
Aortic single cells were incubated with 0.00134% of 0.50mm Fluoresbrite YG
Microspheres (Polysciences) for 70 min at 37 C. The cells were washed with
cold PBS twice. Then the cells were labeled with mAbs to CD45, CD11c,
MHC II, and CD11b and analyzed with ImageStream (Amnis) or flow cytometry
(BD LSRII).
En Face Immunostaining and Confocal Microscopic Analysis
The aorta was perfused with cold 4% paraformaldehyde in PBS via the left
ventricle. After removing perivascular tissues, segments of aortic sinus, aortic
arch, and thoracic aorta were opened longitudinally and further fixed in 4%
paraformaldehyde at 4 C for 30 min. After permeabilization with 0.2% Triton
X-100, staining for CD11c, CD11b, and F4/80 was performed using Alexa
488 and Alexa 568 TSA kit (Invitrogen) following the manufacturer’s protocol.
After staining, the aortic segments were mounted on glass slides with aqueous
mounting medium. The confocal images of en face immunostaining were
obtained with a Zeiss 510 Meta inverted laser scanning microscope. All
confocal sections were taken along the Z axis for visualizing all processes
from each DC.
Bone Marrow Chimeras
Mixtures (50:50) of marrow from CD45.2+ LysM-Cre 3 iDTR and CD45.1+ WT
mice were intravenously (i.v.) injected to lethally irradiated (5.5 Gy, 3 hr apart)
CD45.1 mice. After 6 weeks, DT (25 ng/g weight) was i.v. injected and the
aortic leukocyte populations were analyzed.
Mixed Leukocyte Reactions
The aortic DC populations (CD45+CD11c+MHC IIhi) and macrophages (CD45+
CD11c CD11b+) were isolated from single-cell suspensions of aorta with
FACS sorting (BD FACS Vantage or FACSAria). Allogeneic T cells were isolated
from spleens of BALB/C mice by excluding B220+, F4/80+, CD49b+, and I-Ab+
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cells with anti-rat IgG Dynalbeads (Invitrogen). T cells were added to roundbottom microtest wells at 25,000/well and mixed with isolated DCs at
a DC:T cell ratio of 1:2 and 1:10. After 5 days, the proliferation of T cells was
evaluated by CFSE dilution on the FACS.
Assessment of Atherosclerosis
In mouse models of atherosclerosis, the atherosclerosis-prone areas are the
aortic sinus, lesser curvature of aortic arch, and the openings of arterial
branches. The lesions appear in the aortic sinus, and as the diet is prolonged,
the atherosclerotic lesions appear in other parts of aorta including the aortic
arch and opening of arterial branches. Here, we analyzed atherosclerosis in
two different atherosclerosis-prone areas the aortic sinus and aortic arch.
Ldlr / mice fed a high-fat diet with 0.15% cholesterol and 20% fat but no
sodium cholate (Harlan) for 12 or 16 wks were euthanized with CO2 inhalation.
The heart and aorta were perfused with cold 4% paraformaldehyde through
the left ventricle. After additional fixation, the heart was embedded in OCT
and frozen. Aorta was dissected from the proximal ascending aorta to thoracic
aorta, and adventitial fat was removed. For en face analysis, aorta was split
longitudinally, pinned onto flat black silicone plates, and stained with oil red
O for 4 hr, washed with PBS briefly, and digitally photographed at a fixed
magnification. Total aortic areas and lesion areas were calculated with Axio
Vision (Carl Zeiss, German). For analyzing aortic sinus plaque lesions, cryosections were stained with oil red O overnight and digitized.
Quantitative Real-Time PCR
Total aortic RNA was isolated with Trizol reagent (Invitrogen), and cDNA was
synthesized with the Superscript III First-strand synthesis system (Invitrogen,
Carlsbad, CA, USA). Quantitative real-time RT-PCR was performed using
a 7700 sequence detector (Applied Biosystems, Foster City, CA, USA) with
mouse IFN-g, TNF-a, and GAPDH primers and probes (Applied Biosystems,
Assay-on-DemandTM). The absolute number of gene copies was normalized
with GAPDH and standardized using a sample standard curve.
Statistical Analysis
Results were analyzed with Mann-Whitney U test or unpaired Student’s
t test with two-tailed distributions (GraphPad Instat) when two groups were
compared, or Kruskal-Wallis test followed by Mann-Whitney U test, for
comparisons of more groups relative to the control group.
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N., Tripp, C.H., Douillard, P., Leserman, L., Kaiserlian, D., et al. (2005).
Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells
colonize lymph node areas distinct from slower migrating Langerhans cells.
Immunity 22, 643–654.
Kuivaniemi, H., Platsoucas, C.D., and Tilson, M.D., 3rd. (2008). Aortic aneurysms: An immune disease with a strong genetic component. Circulation
117, 242–252.
Lessner, S.M., Prado, H.L., Waller, E.K., and Galis, Z.S. (2002). Atherosclerotic
lesions grow through recruitment and proliferation of circulating monocytes in
a murine model. Am. J. Pathol. 160, 2145–2155.
Liu, P., Yu, Y.R., Spencer, J.A., Johnson, A.E., Vallanat, C.T., Fong, A.M.,
Patterson, C., and Patel, D.D. (2008). CX3CR1 deficiency impairs dendritic
cell accumulation in arterial intima and reduces atherosclerotic burden.
Arterioscler. Thromb. Vasc. Biol. 28, 243–250.
Liu, K., Victora, G.D., Schwickert, T.A., Guermonprez, P., Meredith, M.M., Yao,
K., Chu, F.F., Randolph, G.J., Rudensky, A.Y., and Nussenzweig, M.C. (2009).
In vivo analysis of dendritic cell development and homeostasis. Science 324,
392–397.
Mallat, Z., Gojova, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., Tedgui,
A., and Groux, H. (2003). Induction of a regulatory T cell type 1 response
reduces the development of atherosclerosis in apolipoprotein E-knockout
mice. Circulation 108, 1232–1237.
Matthews, W., Jordan, C.T., Wiegand, G.W., Pardoll, D., and Lemischka, I.R.
(1991). A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65, 1143–1152.
Merad, M., and Manz, M.G. (2009). Dendritic cell homeostasis. Blood 113,
3418–3427.

830 Immunity 35, 819–831, November 23, 2011 ª2011 Elsevier Inc.

Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T.,
Keren, G., and George, J. (2007). Role of naturally occurring CD4+ CD25+
regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb.
Vasc. Biol. 27, 893–900.
Naik, S.H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O’Keeffe, M.,
and Shortman, K. (2006). Intrasplenic steady-state dendritic cell precursors
that are distinct from monocytes. Nat. Immunol. 7, 663–671.
Ohnmacht, C., Pullner, A., King, S.B., Drexler, I., Meier, S., Brocker, T., and
Voehringer, D. (2009). Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp.
Med. 206, 549–559.
Onai, N., Obata-Onai, A., Tussiwand, R., Lanzavecchia, A., and Manz, M.G.
(2006). Activation of the Flt3 signal transduction cascade rescues and
enhances type I interferon-producing and dendritic cell development.
J. Exp. Med. 203, 227–238.
Paulson, K.E., Zhu, S.N., Chen, M., Nurmohamed, S., Jongstra-Bilen, J., and
Cybulsky, M.I. (2010). Resident intimal dendritic cells accumulate lipid and
contribute to the initiation of atherosclerosis. Circ. Res. 106, 383–390.
Rajavashisth, T., Qiao, J.H., Tripathi, S., Tripathi, J., Mishra, N., Hua, M., Wang,
X.P., Loussararian, A., Clinton, S., Libby, P., and Lusis, A. (1998).
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL
receptor- deficient mice. J. Clin. Invest. 101, 2702–2710.
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